(Q44840763)

6 December 2017

title

p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c-erbB-2 expression (English)

1 reference

6 December 2017

Wiesener B

1

1 reference

6 December 2017

Hauser-Kronberger CE

2

1 reference

6 December 2017

Zipperer E

3

1 reference

6 December 2017

Dietze O

4

1 reference

6 December 2017

Menzel C

5

1 reference

6 December 2017

Hacker GW

6

1 reference

6 December 2017

publication date

1 December 1998

1 reference

6 December 2017

1 reference

6 December 2017

volume

33

1 reference

6 December 2017

issue

6

1 reference

6 December 2017

page(s)

522-530

1 reference

p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Survival and age at diagnosis of breast cancer in a population-based cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Breast cancer risk factors. Contributions to planning breast cancer control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Expression of C-erbB-2 Oncoprotein in Mammary and Extramammary Paget's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

c-erbB-2 oncogene as a prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Cyclin is a component of maturation-promoting factor from Xenopus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Cyclin is degraded by the ubiquitin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

The requirements for protein synthesis and degradation, and the control of destruction of cyclins A and B in the meiotic and mitotic cell cycles of the clam embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Control of programmed cyclin destruction in a cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2-mitotic B cyclin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Tumour DNA ploidy as an independent prognostic factor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

DNA index, S-phase fraction, histological grade and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Node negative breast cancer: The prognostic value of DNA ploidy for long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Cytometric DNA analysis in the management of cancer. Clinical and laboratory considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00500.X

10.1046/J.1365-2559.1998.00500.X

21 January 2018

Identifiers

DOI

1 reference

release_5mdavhbyozeorl3o6lraq2ercm

6 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5mdavhbyozeorl3o6lraq2ercm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference